锦波生物 — Investor Relations & Filings
About 锦波生物
Shanxi Jinbo Bio-Pharmaceutical Co., Ltd. specializes in the research, development, and manufacturing of functional proteins through synthetic biology. The company is recognized for its industrialization of recombinant humanized collagen, specifically Type III collagen with a stable triple helix structure. Its core business encompasses the production of medical-grade biomaterials, functional skincare products, and medical devices used in aesthetics, wound healing, and gynecological health. By utilizing advanced protein engineering, the company provides biocompatible solutions designed for tissue repair and anti-aging applications. Its technical focus remains on the structural optimization and large-scale production of high-purity recombinant proteins to meet clinical and consumer health demands.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年年度权益分派预案公告 | 2026-04-28 | Chinese | |
| 关于调整2025年股票期权激励计划行权价格的公告 | 2026-04-28 | Chinese | |
| 关于山西锦波生物医药股份有限公司注销2025年股票期权激励计划部分股票期权的法律意见书 | 2026-04-28 | Chinese | |
| 中汇会计师事务所（特殊普通合伙）2025年度履职情况评估报告 | 2026-04-28 | Chinese | |
| 中信证券股份有限公司关于山西锦波生物医药股份有限公司使用闲置自有资金购买理财产品的核查意见 | 2026-04-28 | Chinese | |
| 关于山西锦波生物医药股份有限公司2025年度募集资金存放、管理与实际使用情况的专项核查报告 | 2026-04-28 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39794257 | 2025年年度权益分派预案公告 | 2026-04-28 | Chinese | ||
| 39794244 | 关于调整2025年股票期权激励计划行权价格的公告 | 2026-04-28 | Chinese | ||
| 39794234 | 关于山西锦波生物医药股份有限公司注销2025年股票期权激励计划部分股票期权的法律意见书 | 2026-04-28 | Chinese | ||
| 39794228 | 中汇会计师事务所（特殊普通合伙）2025年度履职情况评估报告 | 2026-04-28 | Chinese | ||
| 39794217 | 中信证券股份有限公司关于山西锦波生物医药股份有限公司使用闲置自有资金购买理财产品的核查意见 | 2026-04-28 | Chinese | ||
| 39794209 | 关于山西锦波生物医药股份有限公司2025年度募集资金存放、管理与实际使用情况的专项核查报告 | 2026-04-28 | Chinese | ||
| 39794201 | 关于购买董事、高级管理人员责任险的公告 | 2026-04-28 | Chinese | ||
| 39794195 | 关于山西锦波生物医药股份有限公司非经营性资金占用及其他关联资金往来情况的专项审核说明 | 2026-04-28 | Chinese | ||
| 39794170 | 2025年度独立董事述职报告（张金鑫已离任） | 2026-04-28 | Chinese | ||
| 39794162 | 2025年度内部控制有效性自我评价报告 | 2026-04-28 | Chinese | ||
| 39794153 | 2025年度董事会工作报告 | 2026-04-28 | Chinese | ||
| 39794142 | 拟续聘 2026 年度会计师事务所公告 | 2026-04-28 | Chinese | ||
| 39794136 | 2026年度董事、高级管理人员薪酬方案的公告 | 2026-04-28 | Chinese | ||
| 39794123 | 2025年年度报告 | 2026-04-28 | Chinese | ||
| 39794064 | 2025年度独立董事述职报告（阎丽明） | 2026-04-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
锦波生物 via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58970/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58970 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58970 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58970 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58970}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 锦波生物 (id: 58970)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.